{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/CUVL",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Clinuvel Pharmaceuticals Ltd (NASDAQ: CUVL) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Clinuvel Pharmaceuticals Ltd, listed on NASDAQ under ticker CUVL, with ISIN US1887691038 and LEI 5299004VJH3VCYLK6519. Its security type is non-operating entity type (other), its segment is not on the record, its sector is 8880 American Depositary Receipts, and its jurisdiction is Australia. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 35 filings across 28 filing days in the window 2025-11-08 to 2026-11-08, comprising 1 prospectus, 18 regulatory filings and 16 results. The median gap between filing days is 8 days, and the median latency from the latest filing to the record date is 9 days. The NASDAQ median cadence gap is 6.0 days across 4359 issuers, with a median of 52 filings and a median latency of 5.0 days. The sector node 8880 American Depositary Receipts has one issuer, so no median is stated. The latest filing is dated 2026-10-30 and is of type results.\n\n## Auditor\n\nThe auditor of record is not on the record, because the latest annual report cover carries no dei:AuditorName tag. Its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds one listing dated 2026-07-17. It holds no delisting, no name change, and no dated domicile change, and the segment move is not on the record. The issuer is listed, not halted.\n\n## Orderability\n\nThe orderability outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 8 research houses: Bioshares, MA Moelis Australia, Jefferies Australia, Morningstar, Wilsons Advisory, Bell Potter Securities, Morgans Financial and Barrenjoey.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe sealed years that hold the issuer are 2021, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001290877.json (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/CUVL (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.clinuvel.com/investor/analyst-coverage/ (coverage)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/CUVL (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/CUVL",
  "coverage": {
   "count": 8,
   "houses": [
    {
     "house": "Bioshares",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.clinuvel.com/investor/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Sarah Mann",
     "house": "MA Moelis Australia",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "since": "17 April 2019",
     "source": "https://www.clinuvel.com/investor/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "David Stanton & Vanessa Thomson",
     "house": "Jefferies Australia",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "since": "13 October 2020",
     "source": "https://www.clinuvel.com/investor/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Shane Ponraj",
     "house": "Morningstar",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "since": "15 November 2023",
     "source": "https://www.clinuvel.com/investor/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Shane Storey",
     "house": "Wilsons Advisory",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.clinuvel.com/investor/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Thomas Wakim & John Hester",
     "house": "Bell Potter Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.clinuvel.com/investor/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Iain Wilkie, Derek Jellinek & Emily Porter",
     "house": "Morgans Financial",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.clinuvel.com/investor/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Melissa Benson & Kieren Young",
     "house": "Barrenjoey",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.clinuvel.com/investor/analyst-coverage/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.clinuvel.com/investor/analyst-coverage/",
     "result": "read: 8 of 12 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "stated per house where the page states it",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 1,
     "name": "8880 American Depositary Receipts",
     "note": "fewer than five issuers on this node: no median is stated"
    }
   },
   "by_type": {
    "prospectus": 1,
    "regulatory_filing": 18,
    "results": 16
   },
   "cadence_median_gap_days": 8,
   "filing_days": 28,
   "filings": 35,
   "latency_days": 9,
   "latest": [
    {
     "category": "20-F",
     "date": "2026-10-30",
     "source": "https://www.sec.gov/Archives/edgar/data/1290877/000149315226049364/form20-f.htm",
     "title": "20-F — 20-F",
     "type": "results"
    },
    {
     "category": "6-K",
     "date": "2026-10-30",
     "source": "https://www.sec.gov/Archives/edgar/data/1290877/000149315226049334/form6-k.htm",
     "title": "6-K — 6-K",
     "type": "results"
    },
    {
     "category": "6-K",
     "date": "2026-10-15",
     "source": "https://www.sec.gov/Archives/edgar/data/1290877/000149315226047083/form6-k.htm",
     "title": "6-K — 6-K",
     "type": "results"
    },
    {
     "category": "6-K",
     "date": "2026-10-07",
     "source": "https://www.sec.gov/Archives/edgar/data/1290877/000149315226046056/form6-k.htm",
     "title": "6-K — 6-K",
     "type": "results"
    },
    {
     "category": "6-K",
     "date": "2026-10-02",
     "source": "https://www.sec.gov/Archives/edgar/data/1290877/000149315226045459/form6-k.htm",
     "title": "6-K — 6-K",
     "type": "results"
    }
   ],
   "latest_filing_date": "2026-10-30",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/CUVL",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-14",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US1887691038"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001290877.json",
    "state": "sourced",
    "value": "Australia"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN US1887691038)",
    "state": "sourced",
    "value": "5299004VJH3VCYLK6519"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001290877.json",
    "state": "sourced",
    "value": "Clinuvel Pharmaceuticals Ltd"
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001290877.json",
    "state": "sourced",
    "value": "8880 American Depositary Receipts"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001290877.json",
    "state": "sourced",
    "value": "Non-operating entity type (other)"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "CUVL"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [
    {
     "date": "2026-07-17",
     "source": "https://www.sec.gov/Archives/edgar/data/1290877/000135445726000700/CUVL_20F_Cert_0001290877.pdf",
     "title": "CERT"
    }
   ],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:f2b0227c4726f0e318d9ca9562ec1ebc86cd12903c59e4bfb90415512fb0d63b",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/CUVL",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:f2b0227c4726f0e318d9ca9562ec1ebc86cd12903c59e4bfb90415512fb0d63b",
 "path": "/us/NASDAQ/CUVL",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Clinuvel Pharmaceuticals Ltd, listed on NASDAQ under ticker CUVL, with ISIN US1887691038 and LEI 5299004VJH3VCYLK6519. Its security type is non-operating entity type (other), its segment is not on the record, its sector is 8880 American Depositary Receipts, and its jurisdiction is Australia. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 35 filings across 28 filing days in the window 2025-11-08 to 2026-11-08, comprising 1 prospectus, 18 regulatory filings and 16 results. The median gap between filing days is 8 days, and the median latency from the latest filing to the record date is 9 days. The NASDAQ median cadence gap is 6.0 days across 4359 issuers, with a median of 52 filings and a median latency of 5.0 days. The sector node 8880 American Depositary Receipts has one issuer, so no median is stated. The latest filing is dated 2026-10-30 and is of type results.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, because the latest annual report cover carries no dei:AuditorName tag. Its location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds one listing dated 2026-07-17. It holds no delisting, no name change, and no dated domicile change, and the segment move is not on the record. The issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The orderability outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 8 research houses: Bioshares, MA Moelis Australia, Jefferies Australia, Morningstar, Wilsons Advisory, Bell Potter Securities, Morgans Financial and Barrenjoey.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The sealed years that hold the issuer are 2021, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001290877.json"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/CUVL"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.clinuvel.com/investor/analyst-coverage/"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/CUVL"
  }
 ],
 "title": "Clinuvel Pharmaceuticals Ltd (CUVL) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}